share_log

JP Morgan Upgrades CytomX Therapeutics to Neutral

Moomoo 24/7 ·  Apr 22 08:18

JP Morgan analyst Anupam Rama upgrades CytomX Therapeutics (NASDAQ:CTMX) from Underweight to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment